Back to Search
Start Over
Influenza vaccination in the elderly
- Source :
- PLoS ONE, PLoS ONE, Vol 14, Iss 5, p e0216983 (2019), PLOS ONE, 14(5):0216983. Public Library of Science
- Publication Year :
- 2019
- Publisher :
- Public Library of Science, 2019.
-
Abstract
- Influenza vaccination is proven effective in preventing influenza. However, long-term effects on mortality have never been supported by direct evidence. In this study we assessed the long-term outcome of influenza vaccination on mortality in the elderly by conducting a 25-year follow-up study of a RCT on the efficacy of influenza vaccination as baseline. The RCT had been conducted in the Netherlands 5 years before vaccination was recommended for those aged >65 and 17 years before recommending it for those aged >60. The RCT included 1838 community-dwelling elderly aged ≥ 60 that had received an intramuscular injection with the inactivated quadrivalent influenza vaccine (n = 927) or placebo (n = 911) during the 1991/1992 winter. In our follow-up study, outcomes included all-cause mortality, influenza-related mortality and seasonal mortality. Unadjusted and adjusted hazard ratios (HRs) were estimated by Cox regression and sub-hazard ratios (SHRs) by competing risk models. Secondary analyses included subgroup analyses by age and disease status. The vital status up to January 1, 2017 was provided in 1800/1838 (98%) of the cases. Single influenza vaccination did not reduce all-cause mortality when compared to placebo (adjusted HR 0.95, 95% CI 0.85−1.05). Also, no differences between vaccination and placebo group were shown for underlying causes of death or seasonal mortality. In those aged 60–64, median survival increased with 20.1 months (95% CI 2.4–37.9), although no effects on all-cause mortality (adjusted HR 0.86, 95% CI 0.72−1.03) could be demonstrated in survival analysis. In conclusion, this study did not demonstrate a statistically significant effect following single influenza vaccination on long-term mortality in community-dwelling elderly in general. We propose researchers designing future studies on influenza vaccination in the elderly to fit these studies for longer-term follow-up, and suggest age-group comparisons in observational research. Clinical trial registry number: NTR6179.
- Subjects :
- Male
Viral Diseases
Kaplan-Meier Estimate
Cardiovascular Medicine
DISEASE
law.invention
0302 clinical medicine
Elderly
Endocrinology
Randomized controlled trial
law
Cause of Death
Medicine and Health Sciences
Medicine
Public and Occupational Health
030212 general & internal medicine
Cause of death
Netherlands
Geriatrics
Vaccines
Multidisciplinary
Mortality rate
RESPIRATORY SYNCYTIAL-VIRUS
Hazard ratio
Middle Aged
Vaccination and Immunization
Vaccination
Treatment Outcome
Infectious Diseases
BIAS
Influenza Vaccines
Cardiovascular Diseases
Female
Seasons
Research Article
Risk
medicine.medical_specialty
Infectious Disease Control
DEATHS
Endocrine Disorders
Death Rates
Science
Immunology
SEASONAL INFLUENZA
03 medical and health sciences
Population Metrics
PEOPLE
Internal medicine
Influenza, Human
BENEFITS
Diabetes Mellitus
Humans
Mortality
Survival analysis
METAANALYSIS
Aged
Proportional Hazards Models
US
Population Biology
business.industry
Proportional hazards model
Biology and Life Sciences
Influenza
030228 respiratory system
Age Groups
Metabolic Disorders
People and Places
Population Groupings
Preventive Medicine
HOSPITALIZATIONS
business
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 14
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- PLOS ONE
- Accession number :
- edsair.doi.dedup.....c94839bcd1134e7c345cc42c00e2930f
- Full Text :
- https://doi.org/10.1371/journal.pone.0216983